Abstract
The discovery of a small-molecule allosteric inhibitor of the CDC34 ubiquitin-conjugating enzyme (E2) by Ceccarelli et al. raises the possibility that it will be generally feasible to selectively inhibit ubiquitin transfer at this central step in the ubiquitin pathway. © 2011 Elsevier Inc.
Cite
CITATION STYLE
APA
Harper, J. W., & King, R. W. (2011, June 24). Stuck in the middle: Drugging the ubiquitin system at the E2 step. Cell. Elsevier B.V. https://doi.org/10.1016/j.cell.2011.06.002
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free